Literature DB >> 25667263

Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.

Kara J Levinson1, Magdia De Jesus2, Nicholas J Mantis3.   

Abstract

2D6 is a dimeric monoclonal immunoglobulin A (IgA) specific for the nonreducing terminal residue of Ogawa O-polysaccharide (OPS) of Vibrio cholerae. It was previously demonstrated that 2D6 IgA is sufficient to passively protect suckling mice from oral challenge with virulent V. cholerae O395. In this study, we sought to define the mechanism by which 2D6 IgA antibody protects the intestinal epithelium from V. cholerae infection. In a mouse ligated-ileal-loop assay, 2D6 IgA promoted V. cholerae agglutination in the intestinal lumen and limited the ability of the bacteria to associate with the epithelium, particularly within the crypt regions. In vitro fluorescence digital video microscopy analysis of antibody-treated V. cholerae in liquid medium revealed that 2D6 IgA not only induced the rapid (5- to 10-min) onset of agglutination but was an equally potent inhibitor of bacterial motility. Scanning electron microscopy showed that 2D6 IgA promoted flagellum-flagellum cross-linking, as well as flagellar entanglement with bacterial bodies, suggesting that motility arrest may be a consequence of flagellar tethering. However, monovalent 2D6 Fab fragments also inhibited V. cholerae motility, demonstrating that antibody-mediated agglutination and motility arrest are separate phenomena. While 2D6 IgA is neither bactericidal nor bacteriostatic, exposure of V. cholerae to 2D6 IgA (or Fab fragments) resulted in a 5-fold increase in surface-associated blebs, as well an onset of a wrinkled surface morphotype. We propose that the protective immunity conferred by 2D6 IgA is the result of multifactorial effects on V. cholerae, including agglutination, motility arrest, and possibly outer membrane stress.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25667263      PMCID: PMC4363435          DOI: 10.1128/IAI.02856-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

Review 1.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

2.  Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo.

Authors:  Armelle Phalipon; Ana Cardona; Jean Pierre Kraehenbuhl; Léna Edelman; Philippe J Sansonetti; Blaise Corthésy
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

3.  Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Authors:  Anne L Bishop; Stefan Schild; Bharathi Patimalla; Brian Klein; Andrew Camilli
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

4.  Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Authors:  Marcela F Pasetti; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

Review 5.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

Review 6.  Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut.

Authors:  N J Mantis; N Rol; B Corthésy
Journal:  Mucosal Immunol       Date:  2011-10-05       Impact factor: 7.313

7.  Delineation of pilin domains required for bacterial association into microcolonies and intestinal colonization by Vibrio cholerae.

Authors:  T J Kirn; M J Lafferty; C M Sandoe; R K Taylor
Journal:  Mol Microbiol       Date:  2000-02       Impact factor: 3.501

8.  Evaluation of the biological properties of different classes of human antibodies in relation to cholera.

Authors:  A S Majumdar; A C Ghose
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

9.  Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.

Authors:  Li Liu; Hope L Johnson; Simon Cousens; Jamie Perin; Susana Scott; Joy E Lawn; Igor Rudan; Harry Campbell; Richard Cibulskis; Mengying Li; Colin Mathers; Robert E Black
Journal:  Lancet       Date:  2012-05-11       Impact factor: 79.321

10.  Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA.

Authors:  Stephen J Forbes; Tia Bumpus; Elizabeth A McCarthy; Blaise Corthésy; Nicholas J Mantis
Journal:  mBio       Date:  2011-05-24       Impact factor: 7.867

View more
  19 in total

1.  High-avidity IgA protects the intestine by enchaining growing bacteria.

Authors:  Kathrin Moor; Médéric Diard; Mikael E Sellin; Boas Felmy; Sandra Y Wotzka; Albulena Toska; Erik Bakkeren; Markus Arnoldini; Florence Bansept; Alma Dal Co; Tom Völler; Andrea Minola; Blanca Fernandez-Rodriguez; Gloria Agatic; Sonia Barbieri; Luca Piccoli; Costanza Casiraghi; Davide Corti; Antonio Lanzavecchia; Roland R Regoes; Claude Loverdo; Roman Stocker; Douglas R Brumley; Wolf-Dietrich Hardt; Emma Slack
Journal:  Nature       Date:  2017-04-12       Impact factor: 49.962

2.  A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.

Authors:  Kara J Levinson; Danielle E Baranova; Nicholas J Mantis
Journal:  Vaccine       Date:  2016-10-20       Impact factor: 3.641

Review 3.  Adaptive immune education by gut microbiota antigens.

Authors:  Qing Zhao; Charles O Elson
Journal:  Immunology       Date:  2018-02-08       Impact factor: 7.397

4.  Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.

Authors:  Zhu Wang; David W Lazinski; Andrew Camilli
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

5.  Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies.

Authors:  Danielle E Baranova; Graham G Willsey; Kara J Levinson; Carol Smith; Joseph Wade; Nicholas J Mantis
Journal:  Pathog Dis       Date:  2020-06-01       Impact factor: 3.166

Review 6.  Tango of B cells with T cells in the making of secretory antibodies to gut bacteria.

Authors:  Ludvig M Sollid; Rasmus Iversen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-02       Impact factor: 73.082

7.  Highlights of the 8th International Conference on Vaccines for Enteric Diseases: the Scottish Encounter To Defeat Diarrheal Diseases.

Authors:  Sharon M Tennant; A Duncan Steele; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

8.  High-molecular-weight polymers from dietary fiber drive aggregation of particulates in the murine small intestine.

Authors:  Asher Preska Steinberg; Sujit S Datta; Thomas Naragon; Justin C Rolando; Said R Bogatyrev; Rustem F Ismagilov
Journal:  Elife       Date:  2019-01-22       Impact factor: 8.140

9.  LPS-binding IgG arrests actively motile Salmonella Typhimurium in gastrointestinal mucus.

Authors:  Holly A Schroeder; Jay Newby; Alison Schaefer; Babu Subramani; Alan Tubbs; M Gregory Forest; Ed Miao; Samuel K Lai
Journal:  Mucosal Immunol       Date:  2020-03-02       Impact factor: 7.313

10.  Passive Immunity to Vibrio cholerae O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in Milk.

Authors:  Danielle E Baranova; Lihow Chen; Margaret Destrempes; Harry Meade; Nicholas J Mantis
Journal:  Pathog Immun       Date:  2020-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.